These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16764960)

  • 21. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.
    Yang ZR; Wang HF; Zhao J; Peng YY; Wang J; Guinn BA; Huang LQ
    Cancer Gene Ther; 2007 Jul; 14(7):599-615. PubMed ID: 17479105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer angiogenesis: targeting the heel of Achilles.
    Dass CR; Choong PF
    J Drug Target; 2008 Jul; 16(6):449-54. PubMed ID: 18604657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
    Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
    Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
    J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterically stabilized liposomes in cancer therapy and gene delivery.
    Lasic DD; Vallner JJ; Working PK
    Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International symposium on new leads in experimental and clinical gene targeting in cancer.
    Zänker KS; Brentani R; Mihich E
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):258-61. PubMed ID: 12687352
    [No Abstract]   [Full Text] [Related]  

  • 28. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for cardiac arrhythmias: a dream soon to come true?
    Donahue JK
    J Cardiovasc Electrophysiol; 2007 May; 18(5):553-9. PubMed ID: 17456137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bifunctional compounds for targeted hepatic gene delivery.
    Kim KS; Lei Y; Stolz DB; Liu D
    Gene Ther; 2007 Apr; 14(8):704-8. PubMed ID: 17287859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
    Mairs RJ; Fullerton NE; Cosimo E; Boyd M
    Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic co-administration of depsipeptide selectively targets transfection enhancement to specific tissues and cell types.
    Liu Y; Liggitt D; Fong S; Debs RJ
    Gene Ther; 2006 Dec; 13(24):1724-30. PubMed ID: 16886001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Search for "weapons of mass destruction" for cancer -- immuno/ gene therapy comes of age.
    Wei MQ; Metharom P; Ellem KA; Barth S
    Cell Mol Immunol; 2005 Oct; 2(5):351-7. PubMed ID: 16368061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase--for colorectal cancer.
    Chaszczewska-Markowska M; Stebelska K; Sikorski A; Madej J; Opolski A; Ugorski M
    Cancer Lett; 2008 Apr; 262(2):164-72. PubMed ID: 18291575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide.
    Ko YT; Hartner WC; Kale A; Torchilin VP
    Gene Ther; 2009 Jan; 16(1):52-9. PubMed ID: 18701915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting the tumor microenvironment in the development of targeted cancer gene therapy.
    Dougherty GJ; Dougherty ST
    Cancer Gene Ther; 2009 Mar; 16(3):279-90. PubMed ID: 18818709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone.
    Sato Y; Murase K; Kato J; Kobune M; Sato T; Kawano Y; Takimoto R; Takada K; Miyanishi K; Matsunaga T; Takayama T; Niitsu Y
    Nat Biotechnol; 2008 Apr; 26(4):431-42. PubMed ID: 18376398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.